EN DE
STOCK COMPARISON

Zhejiang Anglikang Pharmaceutical Co Ltd Class A vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Zhejiang Anglikang Pharmaceutical Co Ltd Class A as the less overvalued of the two: Zhejiang Anglikang Pharmaceutical Co Ltd Class A trades at ¥26.38 versus a fair value of ¥13.68 (-48%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).
Zhejiang Anglikang Pharmaceutical Co Ltd Class A
002940.SHE · CNY · Health Care
-48%
upside to fair value
overvalued
Price¥26.38
Fair Value¥13.68
Quality65/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-53%
upside to fair value
overvalued
Price¥54.62
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Zhejiang Anglikang Pharmaceutical Co Ltd Class AJiangsu Hengrui Medicine Co
Valuation
44.7×P/E (TTM)43.6×
4.01×P/S (TTM)10.84×
3.49×P/B5.76×
23.0×EV/EBITDA33.0×
—PEG0.93×
0.9%Dividend yield0.4%
¥0.25Dividend per share¥0.20
Profitability
9%Net margin25%
9%Operating margin32%
8%Return on equity15%
3%Return on assets9%
Growth
-2%Revenue growth (YoY)13%
-3.2%Avg. growth/yr (3Y)13.9%
2.0%Avg. growth/yr (5Y)2.5%
Balance & size
0.15×Debt / equity—
$844MMarket cap$52B
mixedGrowth qualityhealthy

Jiangsu Hengrui Medicine Co leads: 4 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Zhejiang Anglikang Pharmaceutical Co Ltd Class Aof which business quality 66 · market factors 15 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 46
ProfitabilityMargins and returns on capital today
37
63
Quality GrowthAre margins and returns improving?
39
41
CashflowEarnings quality: real cash, not paper profit
74
82
Fin. StrengthBalance sheet, leverage, solvency risk
88
100
InvestmentDisciplined investing over empire-building
85
27
Low VolatilityCalm price path (market factor)
42
78
MomentumPrice trend over the last 3–12 months (market factor)
5
35
52W MomentumDistance to the 52-week high (market factor)
0
29
Net IssuanceBuybacks instead of dilution
74
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A

DCF Models¥15.95
Earnings-Based¥10.11
Dividend Discount¥3.98
Multiples¥14.49
Asset-Based¥5.40
Growth DCF¥15.97
Economic Profit¥9.80
Growth Earnings¥11.11

25 of 25 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A
Bear ¥10.26Fair Value ¥13.68Bull ¥17.10
¥26.38 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Zhejiang Anglikang Pharmaceutical Co Ltd Class A · Health Care

Quality score65 · Top 25%
Fair value upside-48% · below median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-53% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Zhejiang Anglikang Pharmaceutical Co Ltd Class A as the less overvalued of the two: Zhejiang Anglikang Pharmaceutical Co Ltd Class A trades at ¥26.38 versus a fair value of ¥13.68 (-48%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Zhejiang Anglikang Pharmaceutical Co Ltd Class A · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Zhejiang Anglikang Pharmaceutical Co Ltd Class A

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jiangsu Hengrui Medicine Co

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.